Abstract
The mammalian cochlea is the primary auditory sense organ which converts mechanical sound energy to electrical signals conducted by the nervous systems. The cochlear lateral wall, located laterally to the cochlear sensory epithelium in the cochlear duct, contributes auditory function and maintenance of homeostasis in the cochlear fluid through generation of endocochlear potential and K+ recycling from perilymph to endolymph. Although our understanding of the basic mechanisms underlying auditory processing in the cochlea has increased significantly in the last two decades, the structure and function of the cochlear lateral wall seems to have been less appreciated during those periods. This chapter will focus on the cochlear lateral wall in terms of potential as a target for regeneration in particular. First, we will discuss the anatomy of the lateral wall reviewing the recent advance in this field. Next, we will discuss the function of the lateral wall, which is basically demonstrated through the advance of physiological studies, and then we will move on to the molecular basis of the cochlear lateral wall. Finally, we will discuss pathology of the lateral wall and possible strategies for hearing disorder caused by dysfunction of the lateral wall.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
The mammalian cochlea is the primary auditory sense organ which converts mechanical sound energy to electrical signals conducted by the nervous systems. The cochlea comprises three sectioned tubular spaces filled with fluid: the scala vestibuli, scala media, and scala tympani. The scala vestibuli and scala tympani contain perilymph with high sodium and low potassium, whose composition is similar to that of ordinary extracellular fluid, and the scala media, on the other hand, is filled with endolymph with high potassium and low sodium. The cochlear endolymph holds an endocochlear potential (EP) of approximately +80 mV relative to blood plasma and perilymph. The existence of EP and specific ion composition is a distinct characteristic of cochlear endolymph, which is not observed in the extracellular fluids of any other organs in the mammal [1]. The epithelium and connective tissue set just laterally adjacent to the scala media is referred to as the cochlear lateral wall. The cochlear lateral wall is formed by a thick epithelium, the stria vascularis, covering the spiral ligament that comprises fibrocytes and epithelial cells, and a variety of types of cells organize both structures in a finely tuned way of cellular arrangement. The stria vascularis usually covers the whole lateral wall between the spiral prominence and the origin of Reissner’s membrane and is a complex epithelium with numerous blood capillaries within it.
From a historical viewpoint, the plate from Reissner’s 1854 publication illustrates the partitioning of the cochlea [2], suggesting that anatomists in that era would be aware of existence of three fluid-filled spaces in the cochlea. Early anatomists in the second half of the nineteenth century described in detail in their publication the cochlear sensory epithelium, the spiral ganglion, and the structure around sensory epithelium and neurons. Eponyms in the cochlea are still used in the field of basic and clinical science in modern era, as shown in the terminology, for example, Deiters, Hensen, Claudius, Rosenthal, Reissner, Nuel, and so on. However, little seems to have been known about the cochlear lateral wall at that time. In fact, the anatomy of the lateral wall has been revealed through electron microscopy in the 1950s, which is almost a hundred years later since the discovery of the organ of Corti. The early literature on the morphology of the stria vascularis by Nachlas and Lurie [3] and Johnson and Spoendlin [4] has shown morphological evidence which supports the theory that production of endolymph occurs in the stria vascularis. The stria vascularis was also believed to be a source of the positive endolymphatic potential.
Although our understanding of the basic mechanisms underlying auditory processing in the cochlea has increased significantly in the last two decades, the structure and function of the cochlear lateral wall seems to have been less appreciated during those periods. By comparison with the organ of Corti and spiral ganglion, relatively little is known about the roles and function of the cochlear lateral wall. This chapter will focus on the cochlear lateral wall in terms of potential as a target for regeneration in particular. First, we will discuss the anatomy of the lateral wall reviewing the recent advance in this field. Next, we will discuss the function of the lateral wall, which is basically demonstrated through the advance of physiological studies, and then we will move on to the molecular basis of the cochlear lateral wall. Finally, we will discuss pathology of the lateral wall and possible strategies for hearing disorder caused by dysfunction of the lateral wall. The authors would like to apologize in advance to any colleague whose work was not discussed or cited as a result of space limitation.
2 Anatomy of Lateral Wall
The lateral wall, consisting of the medially located stria vascularis and the laterally located spiral ligament, defines the lateral aspect of the scala media. Anatomy of the cochlear lateral wall has been intensively studied by immunohistochemistry and electron microscopy in the 1970s and thereafter. As mentioned above, the cochlea contains two segregated compartment filled with two different compositions of extracellular fluid. While the apex of hair cell faces the endolymphatic space, its lateral side of the cell body and basolateral surface are bathed in perilymph (Fig. 5.1). Acoustically evoked receptor potential is generated by the influx of potassium ions (K+) from endolymph into hair cells. These K+ are secreted basolaterally to the extracellular space and picked up by supporting cells. K+ are transported from supporting cells to the stria vascularis through the cochlear sensory epithelium and the cochlear lateral wall. The marginal cells in the stria vascularis take up K+ and release them back into the endolymph. Regarding ion transporting, cells in the cochlear duct are divided into two systems, epithelial cell gap junction system and connective tissue cell gap junction system, which are connected via intercellular junctions for electrical and ionic coupling among cells in each system. Gap junction channels connect the cytoplasm of adjacent cells, allowing the diffusion of ions and small molecules, which constitutes one of the most important pathways for intercellular communication. These gap junction systems play a key role in the maintenance of ionic and metabolic homeostasis in the cochlea. In the mature mammalian cochlea, five connexin isoforms have been detected, connexin (Cx) 26, Cx29, Cx30, Cx31, and Cx43 [5, 6], which are associated with non-syndromic or syndromic deafness in human. Cx26 and Cx30 are present in all cells constituting the epithelial and connective tissue cell gap junction systems. Recent studies reported that Cx26 and Cx30 are differentially distributed within the non-sensory cells in the organ of Corti, suggesting unique roles of each Cx subtype [7, 8]. Cx31 is confined to the spiral limbus and fibrocytes in the spiral ligament and suprastrial zone and to the auditory nerve [9]. Cx29 is expressed in the Schwann cells surrounding the nerve fibers of spiral ganglion neurons [10, 11]. Cx43 is restricted to cells in the cochlear bony wall and the otic capsule [12, 13].
The fibrocytes in the spiral ligament form a network of ion-transporting connective tissue cell gap junction system that facilitates recycling of K+ from perilymph back to endolymph. Spiral ligament fibrocytes are classified into five types according to characteristics in morphology and immunohistochemistry [14]. Type I fibrocytes are distributed between the stria vascularis and the bony wall of the cochlea and stained for carbonic anhydrase (CA) isozymes II and III and CK isozyme BB. Type I fibrocytes have few cellular processes and contained few cellular organelles in contrast to type II fibrocytes which possessed abundant mitochondria. Type II fibrocytes lie under the outer sulcus and spiral prominence and possess abundant cellular processes. Type II fibrocytes express ion transporters including Na+,K+-ATPase and Na+,K+,2Cl− cotransporter, suggesting that type II fibrocytes are involved in regulation of the solute content in the cochlear lateral wall. Type III fibrocytes are located in the area adjacent to the cochlear bony wall in the inferior region of the spiral ligament. Type III fibrocytes contained not only CA II and III and CK isozymes BB and MM but also various types of cytoskeletal filament including actin, which indicates that type III fibrocytes play roles in metabolism as well as mechanical support for the basilar membrane. Type IV fibrocytes are placed facing to the scala tympani in the inferior part of the superficial spiral ligament. Type IV fibrocytes express Na+,K+-ATPase, CA II and III, and CK. Type V fibrocytes reside in the suprastrial area between the scala vestibuli and the cochlear bony wall. Type V fibrocytes appear heterogenous in terms of expression of ion transporter, the more superficial having predominantly ATPase and the deeper only expressing CA; however, morphological characteristics of type V fibrocytes resemble that of type II fibrocytes. Types II, IV, and V fibrocytes function to pump K+ from the perilymph and produce a K+ flow to type I fibrocytes which are electrically connected to the basal cells in the stria vascularis [15].
The stria vascularis is made up of three layers of cells: marginal cells in the luminal surface to the scala media, the intermediate cells, and basal cells adjacent to the spiral ligament (Fig. 5.2). The marginal cells are a layer of polarized epithelial cells that are derived from the epithelium of the cochlear duct and form the luminal surface of the scala media. Marginal cells are abundant in cytokeratin proteins and also include several molecules associated with ionic plumps and channels. The intermediate cells, which are probably derived from the neural crest, contain melanin and are referred to as melanocytes [16]. When melanocytes are missing in the stria vascularis, EP is not generated and hearing is severely impaired [17]. Basal cells are located lateral to the intermediate cell layer. These flat cells form a continuous layer and a dense network of gap junction complexes with neighboring basal cells. It is not completely clear whether these cells are derived from mesodermal or neural crew origins.
At the lateral extremity of the epithelial cell gap junction system, root cells reside in partwithin the outer sulcus region. The root cells are named after characteristic fingerlike projection from their cell bodies and infiltrate between the mesenchymal fibrocytes of the spiral ligament. They display a graded variation of their gross morphological properties along the tonotopic axis of the cochlear spiral, particularly in terms of the number and size of the root processes. Also, the root cells possess the functional specialization including intercellular tight junction and gap junction [18, 19].
Melanocytes have been known to reside as intermediate cells of the stria vascularis. Intermediate cells express Na+,K+-ATPase and K+ channels which are essential for production of EP. Intrastrial space is quite rich in blood vessels. The vessel wall constitutes the intrastrial fluid-blood carrier of specialized endothelial cells, which are surrounded by pericytes and melanocytes. Perivascular melanocytes in the intrastrial space maintain barrier integrity by controlling tight junction and adherence junction protein expression [20].
Bone marrow-derived cells also are widely distributed in the cochlear lateral wall [21, 22], most of which have phenotypes as tissue-resident macrophages. Specific roles of cochlear resident macrophages are largely unknown; however, macrophages play roles in protection of hair cells following application of ototoxic drugs or innate immune systems in the cochlea [23, 24]. In addition, Hirose et al. reported that bone marrow-derived cells are attracted to the cochlear sensory epithelium when the cochlea is insulted by acoustic overstimulation [25]. These observations suggest that bone marrow-derived cells play substantial roles in maintenance of cochlear function and homeostasis.
3 Physiology of the Cochlear Lateral Wall
The cochlea is the organ that continuously controls water and ion homeostasis for auditory perception. Like the retina, cochlea maintains continuous extracellular potential and ion gradients through transporting ions even in the absence of an acoustic stimulus, which was called “silent current” by Zidanic and Brownell [26]. In addition, these gradients are not generated by hair cells but in the stria vascularis, which benefits significantly for the detection of mechanical stimuli. As generation of EP and K+ recycling from perilymph to endolymph are inseparably connected, we will discuss physiological roles and mechanisms of the cochlear lateral wall in terms of generation of EP.
As described above, the cochlear endolymph exhibits a positive potential of +80 mV, which is called the endocochlear potential. von Bekesy in 1952 first reported the DC potential in endolymph with a +80 mV positive potential to the perilymph [27]. Davis et al. measured the cochlear microphonic and found that the energy of the cochlear microphonic is derived from the polarization potential across the interface between the endolymph and the interior of the hair cells, which is called “battery theory.” In addition, they described that the movements of hair bundles modulate the flow of electric current [28]. These batteries that drive auditory-evoked excitation in hair cell are comprised of electrochemical gradients across the apical surface of hair cell produced by EP. Since then, so many works have been done on the mechanism of generation of EP and high potassium concentration [29, 30]. Salt et al. found the intrastrial space with a positive potential and a low K+ concentration through measurement of the potential and K+ gradient in the stria vascularis using K+-selective electrodes. The results also indicate that EP is not generated by the marginal cells alone but also by K+ movement across the cell membrane of components in the stria vascularis [31]. The works by Salt et al. redefined the investigation for EP as research on cellular compartments and ion pumps that positively transport cation and anion across cellular membrane and intercellularly.
The two-cell model, also referred to as the five-compartment model [32], has been widely accepted as the mechanism for origin of EP [33]. In this hypothesis, the cochlear lateral wall comprises two epithelial compartments, the strial marginal cells and the syncytium that forms cellular complex of fibrocytes, strial basal cells, and strial intermediate cells. Type I fibrocytes, strial basal cells, and strial intermediate cells are interconnected by gap junction network, which means these cells are electrically equivalent. Type I fibrocytes in the cochlear lateral wall express both Na+,K+-ATPase and Na+,K+,2Cl− cotransporter. Vascular perfusion of either ouabain, an inhibitor for Na+,K+-ATPase, or furosemide, an inhibitor for Na+,K+,2Cl− cotransporter, dramatically reduces EP [34, 35], indicating that these two ion transporters are required for generation of EP. The strial intermediate cells express Kir 4.1 [36] which secretes K+ into the intrastrial space. Vascular perfusion of Ba2+, a potential blocker for the Kir family, remarkably suppresses EP [37], suggesting that the K+ diffusion potential is primarily formed by Kir4.1 and critical for generation of EP. Tight junctions between n the basal cells make the syncytium a diffusional barrier and serve as the boundary of the apical surface composed of intermediate cell membranes and the basolateral surface comprising the fibrocyte membranes. Mice lacking Claudin11, a major constituent of tight junctions of basal cells, exhibit disruption of EP despite normal K+ recycling, indicating the importance of basal cell tight junctions in the stria vascularis for generation of EP [38, 39]. The results also support two-cell model that EP is not generated by the marginal cells alone but the intrastrial space contributes generation of endocochlear potential. Expression of Na+,K+-ATPase and Na+,K+,2Cl− cotransporter in the basolateral membrane of the strial marginal cells sustains a low K+ concentration in the extracellular fluid in the intrastrial space. Chloride ions exit from the marginal cells through ClC-Kb chloride channels, Barttin, which is supposed to be essential for K+ recycling in the stria vascularis [40]. KCNq1/KCNE1 K+ channels which are expressed in the apical surface of the marginal cells secrete K+ into the endolymph contributing a K+ diffusion potential and the dynamics of EP [41]. Whereas the basal cells in the stria vascularis express only Claudin11, the marginal cells express a variety of Claudin family including Claudin1, 2, 3, 8, 9, 10, 12, 14, and 18, suggesting importance of the barrier formation in the marginal cells [42]. Researches in the field of physiology and molecular biology have made substantial advance to complete understanding for roles and mechanisms of the cochlear lateral wall. In the next section, we will discuss potential molecular targets for regenerative medicine in the cochlear lateral wall identified in either humans and mice or both.
4 Molecular Basis of the Function of Cochlear Lateral Wall
Several genes that are involved in ion transporting are reported to account for hereditary hearing loss. Mutations in GJB2 encoding connexin 26 are the most prevalent inherited source of congenital hearing loss in humans [43]. In most of these cases, the inheritance type is autosomal recessive; however, some cases of dominant inheritance are also reported. In Gjb2 knockout mice, degeneration of the organ of Corti is observed as early as postnatal day (P)14 and their hearing are profoundly impaired [44]. Endolymphatic K+ concentration and EP are much lower in Gjb2 knockout mice than wild type, suggesting that Cx26 is essential for maintenance and function of the organ of Corti, but is not required for normal development of the cochlear sensory epithelium. A Gjb6 knockout mouse model was also developed, and homozygous mice are hearing impaired and lack EP. Degeneration of the organ of Corti is observed from P18, which is similar to Gjb2 mutant mice [45].
The SLC26 family is responsible for membranous transporting of anion, including chloride, iodide, and bicarbonate. SLC26A4 mutations are associated with syndromic hearing loss, Pendred syndrome, and non-syndromic hereditary hearing loss [46]. Most of the patients display radiologically detectable structural malformations of the inner ear, the most common feature of which is an enlarged vestibular aqueduct. Enlarged endolymphatic ducts are also observed in some patients with non-syndromic hereditary hearing loss due to SLC26A4 mutations. In the mouse inner ear, Slc26a4 is expressed on apical surface of cells covered by the endolymphatic space [47]. Slc26a4 knockout mice exhibit waltzer-like vestibular dysfunction and complete deafness with a severe dilatation of the endolymphatic duct and sac [48]. Functional analyses revealed that Slc26a4 knockout mice gradually loss EP, beginning at P12, before normal onset of hearing despite normal concentration of K+ in the endolymph.
In the cochlea, the essential segregation of endolymph from perilymph is achieved by tight junctions of epithelial cells bordering the fluid compartments. Tight junctions are composed of at least three types of transmembrane proteins: occludin, claudins, and the junction adhesion molecule family. Claudin proteins are widely expressed in the inner ear, with 10 types of claudin proteins of differential distribution or localization [42]. Recessive mutations of human CLDN14 were identified as a source of non-syndromic hearing loss [49]. Claudin14 is detected in tight junctions of the reticular lamina in the organ of Corti in mice, and Claudin14-null mice are deaf, whereas their EP stays normal [50]. Tight junctions in the basal cells of stria vascularis are primarily composed of Claudin11, and Claudin11-deficient mice show severe hearing loss without obvious degeneration of the organ of Corti [39]. In addition, EP in Claudin11-deficient mice is suppressed, while K+ concentration in the endolymph is maintained at almost normal level. These findings indicate that establishment of the basal cell barrier in the stria vascularis is indispensable for hearing function through generation and maintenance of EP.
Kcne1, Kcnq1, and Kcnq4 encode for subunits of low-voltage-activated K+ channel, which are the major determinants of cellular depolarization in excitable cells. Stria vascularis marginal cells secrete K+ into the endolymph by K+ channel composed of Kcnq1 and Kcne1 subunits. Mutations in KCNE1 or KCNQ1 in human induce syndromic hearing loss with cardiac symptoms, including prolonged QT interval in the electrocardiogram and arrhythmias (Jervell and Lange-Nielsen syndrome) [51–53]. Kcne1 or Kcnq1 knockout mice exhibit severe hearing loss and vestibular dysfunction [54, 55]. Although morphology of the cochlear duct is likely to be normal at birth, degeneration develops later after birth including a collapse of Reissner’s membrane and a decrease in the volume of endolymphatic space. Kcnq4 is detected in the basolateral membrane of cochlear hair cells, suggesting that Kcnq4 channels are responsible for secretion of K+ from hair cells to the perilymph [56].
Kir4.1, or KCNJ10, is expressed in the intermediate cells of stria vascularis [57]. K+ concentration as well as EP and volume of the endolymphatic space is reduced in Kcnj10 knockout mice, suggesting that the Kir4.1 channel provides the molecular mechanism for generation of EP in concert with other channels for K+ secretion, as is indicated by the fact that Slc26a4 knockout mice lack Kir4.1 expression in the stria vascularis [58].
In human, Bartter syndrome IV is an autosomal recessive disorder characterized by congenital deafness and severe renal salt and fluid loss, which is caused by mutations in Barttin, a beta-subunit of ClC-Ka and ClC-Kb chloride channels [59]. NKCC, Na+,K+,2Cl− cotransporter, and ClC, Barttin-type Cl− channel are expressed in the basolateral membrane of the stria marginal cells. Barttin-knockout mice demonstrate severe hearing loss with a decrease of EP despite normal concentration of K+ in the endolymph [60]. These observations indicate that Cl− transport in the stria vascularis is also involved in the formation of EP.
Finally, DFN3, an X chromosome-linked non-syndromic mixed deafness, is caused by mutations in the POU3F4 gene, which encodes a POU transcription factor [61, 62]. Pou3f4-deficient mice were created and found to exhibit profound deafness with a dramatic reduction in EP. Histological analyses demonstrated a hypoplasia of fibrocytes in the cochlear lateral wall. The findings suggest that fibrocytes responsible for K+ homeostasis in the lateral wall play a critical role in generating EP and auditory function as well. Taken together, these molecules described above could be potential targets for regenerative medicine to improve hearing in disorders of the cochlear lateral wall through regenerative therapy.
5 Targets of Regenerative Medicine
In human, some types of hearing impairment are clinically suggested to be caused by disorder or damage of the cochlear lateral wall. The most widely referenced scheme for describing age-related hearing loss is one attributed to Schuknecht, in which three major cochlear structures, afferent neuron, organ of Corti, and stria vascularis, can degenerate independently [63, 64]. In addition, an age-related loss of fibrocytes in the spiral ligament has been reported in the basal portion of the mouse cochlea [65]. Moreover, Ohlemiller et al. reported that degeneration of the strial intermediate cells plays essential roles in age-related hearing loss through providing melanin to both the marginal cells and the basal cells [66]. Taken together, the cochlear lateral wall is very likely to be affected in the pathology of presbycusis according to the data shown above.
Pathological changes in fibrocytes have been linked to noise-induced hearing loss as well as age-related hearing loss, where fibrocyte degeneration was shown to precede loss of hair cells and neurons [65]. Widespread degeneration of fibrocytes in the spiral ligament, especially among the type IV fibrocyte areas, was observed in aged mouse cochlea prior to hair cell loss or degeneration of spiral ganglion neurons, suggesting that pathological changes in the fibrocytes in the cochlear lateral wall might be responsible for hair cell degeneration in age-related hearing loss.
Sudden deafness, or sudden-onset unilateral hearing loss due to unknown etiology, is suggested to be caused, at least in part, by damage of the lateral wall. Whereas some studies focused on degeneration of the spiral ganglion or the organ of Corti in models of transient cochlear ischemia [67], recent studies have revealed that the cochlear lateral wall is also affected by cochlear ischemia or energy failure, which seems to be reasonable as vasculature and mitochondrial activity are abundantly distributed in the cochlear lateral wall. In a mouse model of acute mitochondrial dysfunction caused by application of 3-nitropropionic acid, cellular degeneration in the cochlear lateral wall primarily accounts for hearing impairment due to acute energy failure [68]. These clinical entities could be candidate diseases for regenerative medicine in the cochlear lateral wall, whereas much works should be done to elucidate the pathophysiology of each clinical condition in the future.
6 Conclusion
In this chapter, we presented a brief review on the cochlear lateral wall from the viewpoint of regenerative medicine. Recent progress in the field of research in the cochlear lateral wall in the last two decades has made our knowledge on the lateral wall biology remarkably improved. At the same time, we recognize that we are still at an early stage in our understanding of the molecular biology and physiology of the cochlear lateral wall. It would depend on further studies in the future to unveil the precise roles and mechanisms of the lateral wall under normal and affected conditions and develop translational researches to connect basic biology to regenerative medicine.
References
Hibino H, Nin F, Tsuzuki C, Kurachi Y. How is the highly positive endocochlear potential formed? The specific architecture of the stria vascularis and the roles of the ion-transport apparatus. Pflugers Arch. 2010;459(4):521–33. doi:10.1007/s00424-009-0754-z.
Schacht J, Hawkins JE. Sketches of otohistory part 4: a cell by any other name: cochlear eponyms. Audiol Neurootol. 2004;9(6):317–27. doi:10.1159/000081311.
Nachlas NE, Lurie MH. The stria vascularis: review and observations. Laryngoscope. 1951;61(10):989–1003. doi:10.1288/00005537-195110000-00002.
Johnson RL, Spoendlin HH. Structural evidence of secretion in the stria vascularis. Ann Otol Rhinol Laryngol. 1966;75(1):127–38.
Ahmad S, Chen S, Sun J, Lin X. Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. Biochem Biophys Res Commun. 2003;307(2):362–8.
Forge A, Becker D, Casalotti S, Edwards J, Marziano N, Nevill G. Gap junctions in the inner ear: comparison of distribution patterns in different vertebrates and assessment of connexin composition in mammals. J Comp Neurol. 2003;467(2):207–31. doi:10.1002/cne.10916.
Jagger DJ, Forge A. Compartmentalized and signal-selective gap junctional coupling in the hearing cochlea. J Neurosci. 2006;26(4):1260–8. doi:10.1523/JNEUROSCI.4278-05.2006.
Zhao HB, Yu N. Distinct and gradient distributions of connexin26 and connexin30 in the cochlear sensory epithelium of guinea pigs. J Comp Neurol. 2006;499(3):506–18. doi:10.1002/cne.21113.
Lopez-Bigas N, Olive M, Rabionet R, Ben-David O, Martinez-Matos JA, Bravo O, et al. Connexin 31 (GJB3) is expressed in the peripheral and auditory nerves and causes neuropathy and hearing impairment. Hum Mol Genet. 2001;10(9):947–52.
Eiberger J, Kibschull M, Strenzke N, Schober A, Bussow H, Wessig C, et al. Expression pattern and functional characterization of connexin29 in transgenic mice. Glia. 2006;53(6):601–11. doi:10.1002/glia.20315.
Tang W, Zhang Y, Chang Q, Ahmad S, Dahlke I, Yi H, et al. Connexin29 is highly expressed in cochlear Schwann cells, and it is required for the normal development and function of the auditory nerve of mice. J Neurosci. 2006;26(7):1991–9. doi:10.1523/JNEUROSCI.5055-05.2006.
Cohen-Salmon M, Maxeiner S, Kruger O, Theis M, Willecke K, Petit C. Expression of the connexin43- and connexin45-encoding genes in the developing and mature mouse inner ear. Cell Tissue Res. 2004;316(1):15–22. doi:10.1007/s00441-004-0861-2.
Suzuki T, Takamatsu T, Oyamada M. Expression of gap junction protein connexin43 in the adult rat cochlea: comparison with connexin26. J Histochem Cytochem. 2003;51(7):903–12.
Spicer SS, Schulte BA. Differentiation of inner ear fibrocytes according to their ion transport related activity. Hear Res. 1991;56(1–2):53–64.
Spicer SS, Schulte BA. The fine structure of spiral ligament cells relates to ion return to the stria and varies with place-frequency. Hear Res. 1996;100(1–2):80–100.
Hilding DA, Ginzberg RD. Pigmentation of the stria vascularis. The contribution of neural crest melanocytes. Acta Otolaryngol. 1977;84(1–2):24–37.
Steel KP, Barkway C. Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development. 1989;107(3):453–63.
Jagger DJ, Forge A. The enigmatic root cell – emerging roles contributing to fluid homeostasis within the cochlear outer sulcus. Hear Res. 2013;303:1–11. doi:10.1016/j.heares.2012.10.010.
Jagger DJ, Nevill G, Forge A. The membrane properties of cochlear root cells are consistent with roles in potassium recirculation and spatial buffering. J Assoc Res Otolaryngol. 2010. doi:10.1007/s10162-010-0218-3.
Zhang W, Dai M, Fridberger A, Hassan A, Degagne J, Neng L, et al. Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier. Proc Natl Acad Sci U S A. 2012;109(26):10388–93. doi:10.1073/pnas.1205210109.
Lang H, Ebihara Y, Schmiedt RA, Minamiguchi H, Zhou D, Smythe N, et al. Contribution of bone marrow hematopoietic stem cells to adult mouse inner ear: mesenchymal cells and fibrocytes. J Comp Neurol. 2006;496(2):187–201. doi:10.1002/cne.20929.
Okano T, Nakagawa T, Kita T, Kada S, Yoshimoto M, Nakahata T, et al. Bone marrow-derived cells expressing Iba1 are constitutively present as resident tissue macrophages in the mouse cochlea. J Neurosci Res. 2008;86(8):1758–67. doi:10.1002/jnr.21625.
Sato E, Shick HE, Ransohoff RM, Hirose K. Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury. J Assoc Res Otolaryngol. 2010;11(2):223–34. doi:10.1007/s10162-009-0198-3.
Warchol ME, Schwendener RA, Hirose K. Depletion of resident macrophages does not alter sensory regeneration in the avian cochlea. PLoS One. 2012;7(12):e51574. doi:10.1371/journal.pone.0051574.
Hirose K, Discolo CM, Keasler JR, Ransohoff R. Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma. J Comp Neurol. 2005;489(2):180–94. doi:10.1002/cne.20619.
Zidanic M, Brownell WE. Fine structure of the intracochlear potential field. I. The silent current. Biophys J. 1990;57(6):1253–68. doi:10.1016/S0006-3495(90)82644-8.
Von Bekesy G. Resting potentials inside the cochlear partition of the guinea pig. Nature. 1952;169(4293):241–2.
Davis H, Deatherage BH, Eldredge DH, Smith CA. Summating potentials of the cochlea. Am J Physiol. 1958;195(2):251–61.
Offner FF, Dallos P, Cheatham MA. Positive endocochlear potential: mechanism of production by marginal cells of stria vascularis. Hear Res. 1987;29(2–3):117–24.
Sellick PM, Johnstone BM. Production and role of inner ear fluid. Prog Neurobiol. 1975;5(4):337–62.
Salt AN, Melichar I, Thalmann R. Mechanisms of endocochlear potential generation by stria vascularis. Laryngoscope. 1987;97(8 Pt 1):984–91.
Takeuchi S, Ando M, Kakigi A. Mechanism generating endocochlear potential: role played by intermediate cells in stria vascularis. Biophys J. 2000;79(5):2572–82. doi:10.1016/S0006-3495(00)76497-6.
Wangemann P. K+ cycling and the endocochlear potential. Hear Res. 2002;165(1–2):1–9.
Kusakari J, Ise I, Comegys TH, Thalmann I, Thalmann R. Effect of ethacrynic acid, furosemide, and ouabain upon the endolymphatic potential and upon high energy phosphates of the stria vascularis. Laryngoscope. 1978;88(1 Pt 1):12–37.
Wada J, Paloheimo S, Thalmann I, Bohne BA, Thalmann R. Maintenance of cochlear function with artificial oxygen carriers. Laryngoscope. 1979;89(9 Pt 1):1457–73.
Ando M, Takeuchi S. Immunological identification of an inward rectifier K+ channel (Kir4.1) in the intermediate cell (melanocyte) of the cochlear stria vascularis of gerbils and rats. Cell Tissue Res. 1999;298(1):179–83.
Hibino H, Horio Y, Inanobe A, Doi K, Ito M, Yamada M, et al. An ATP-dependent inwardly rectifying potassium channel, KAB-2 (Kir4. 1), in cochlear stria vascularis of inner ear: its specific subcellular localization and correlation with the formation of endocochlear potential. J Neurosci. 1997;17(12):4711–21.
Gow A, Davies C, Southwood CM, Frolenkov G, Chrustowski M, Ng L, et al. Deafness in Claudin 11-null mice reveals the critical contribution of basal cell tight junctions to stria vascularis function. J Neurosci. 2004;24(32):7051–62. doi:10.1523/JNEUROSCI.1640-04.2004.
Kitajiri S, Miyamoto T, Mineharu A, Sonoda N, Furuse K, Hata M, et al. Compartmentalization established by claudin-11-based tight junctions in stria vascularis is required for hearing through generation of endocochlear potential. J Cell Sci. 2004;117(Pt 21):5087–96. doi:10.1242/jcs.01393.
Estevez R, Boettger T, Stein V, Birkenhager R, Otto E, Hildebrandt F, et al. Barttin is a Cl− channel beta-subunit crucial for renal Cl− reabsorption and inner ear K+ secretion. Nature. 2001;414(6863):558–61. doi:10.1038/35107099.
Sunose H, Ikeda K, Suzuki M, Takasaka T. Voltage-activated K channel in luminal membrane of marginal cells of stria vascularis dissected from guinea pig. Hear Res. 1994;80(1):86–92.
Kitajiri SI, Furuse M, Morita K, Saishin-Kiuchi Y, Kido H, Ito J, et al. Expression patterns of claudins, tight junction adhesion molecules, in the inner ear. Hear Res. 2004;187(1–2):25–34.
Zelante L, Gasparini P, Estivill X, Melchionda S, D'Agruma L, Govea N, et al. Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet. 1997;6(9):1605–9.
Cohen-Salmon M, Ott T, Michel V, Hardelin JP, Perfettini I, Eybalin M, et al. Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death. Curr Biol. 2002;12(13):1106–11.
Teubner B, Michel V, Pesch J, Lautermann J, Cohen-Salmon M, Sohl G, et al. Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum Mol Genet. 2003;12(1):13–21.
Li XC, Everett LA, Lalwani AK, Desmukh D, Friedman TB, Green ED, et al. A mutation in PDS causes non-syndromic recessive deafness. Nat Genet. 1998;18(3):215–7. doi:10.1038/ng0398-215.
Everett LA, Morsli H, Wu DK, Green ED. Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci U S A. 1999;96(17):9727–32.
Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, Thakkar SI, et al. Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet. 2001;10(2):153–61.
Wilcox ER, Burton QL, Naz S, Riazuddin S, Smith TN, Ploplis B, et al. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell. 2001;104(1):165–72.
Ben-Yosef T, Belyantseva IA, Saunders TL, Hughes ED, Kawamoto K, Van Itallie CM, et al. Claudin 14 knockout mice, a model for autosomal recessive deafness DFNB29, are deaf due to cochlear hair cell degeneration. Hum Mol Genet. 2003;12(16):2049–61.
Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet. 1997;15(2):186–9. doi:10.1038/ng0297-186.
Schulze-Bahr E, Wang Q, Wedekind H, Haverkamp W, Chen Q, Sun Y, et al. KCNE1 mutations cause Jervell and Lange–Nielsen syndrome. Nat Genet. 1997;17(3):267–8. doi:10.1038/ng1197-267.
Tyson J, Tranebjaerg L, Bellman S, Wren C, Taylor JF, Bathen J, et al. IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange–Nielsen syndrome. Hum Mol Genet. 1997;6(12):2179–85.
Casimiro MC, Knollmann BC, Ebert SN, Vary Jr JC, Greene AE, Franz MR, et al. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc Natl Acad Sci U S A. 2001;98(5):2526–31. doi:10.1073/pnas.041398998.
Vetter DE, Mann JR, Wangemann P, Liu J, McLaughlin KJ, Lesage F, et al. Inner ear defects induced by null mutation of the isk gene. Neuron. 1996;17(6):1251–64.
Kharkovets T, Hardelin JP, Safieddine S, Schweizer M, El-Amraoui A, Petit C, et al. KCNQ4, a K + channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc Natl Acad Sci U S A. 2000;97(8):4333–8.
Marcus DC, Wu T, Wangemann P, Kofuji P. KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol. 2002;282(2):C403–7.
Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, Maganti RJ, et al. Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med. 2004;2:30. doi:10.1186/1741-7015-2-30.
Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Ruf EM, Maier-Lutz I, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet. 2001;29(3):310–4. doi:10.1038/ng752.
Rickheit G, Maier H, Strenzke N, Andreescu CE, De Zeeuw CI, Muenscher A, et al. Endocochlear potential depends on Cl− channels: mechanism underlying deafness in Bartter syndrome IV. Embo J. 2008;27(21):2907–17. doi:10.1038/emboj.2008.203.
Minowa O, Ikeda K, Sugitani Y, Oshima T, Nakai S, Katori Y, et al. Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science. 1999;285(5432):1408–11.
Phippard D, Lu L, Lee D, Saunders JC, Crenshaw 3rd EB. Targeted mutagenesis of the POU-domain gene Brn4/Pou3f4 causes developmental defects in the inner ear. J Neurosci. 1999;19(14):5980–9.
Schuknecht HF, Gacek MR. Cochlear pathology in presbycusis. Ann Otol Rhinol Laryngol. 1993;102(1 Pt 2):1–16.
Schuknecht HF, Watanuki K, Takahashi T, Belal Jr AA, Kimura RS, Jones DD, et al. Atrophy of the stria vascularis, a common cause for hearing loss. Laryngoscope. 1974;84(10):1777–821. doi:10.1288/00005537-197410000-00012.
Hequembourg S, Liberman MC. Spiral ligament pathology: a major aspect of age-related cochlear degeneration in C57BL/6 mice. J Assoc Res Otolaryngol. 2001;2(2):118–29.
Ohlemiller KK, Rice ME, Lett JM, Gagnon PM. Absence of strial melanin coincides with age-associated marginal cell loss and endocochlear potential decline. Hear Res. 2009;249(1–2):1–14. doi:10.1016/j.heares.2008.12.005.
Koga K, Hakuba N, Watanabe F, Shudou M, Nakagawa T, Gyo K. Transient cochlear ischemia causes delayed cell death in the organ of Corti: an experimental study in gerbils. J Comp Neurol. 2003;456(2):105–11. doi:10.1002/cne.10479.
Okamoto Y, Hoya N, Kamiya K, Fujii M, Ogawa K, Matsunaga T. Permanent threshold shift caused by acute cochlear mitochondrial dysfunction is primarily mediated by degeneration of the lateral wall of the cochlea. Audiol Neurootol. 2005;10(4):220–33. doi:10.1159/000084843.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Okano, T. (2014). Cochlear Lateral Wall. In: Ito, J. (eds) Regenerative Medicine for the Inner Ear. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54862-1_5
Download citation
DOI: https://doi.org/10.1007/978-4-431-54862-1_5
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54861-4
Online ISBN: 978-4-431-54862-1
eBook Packages: MedicineMedicine (R0)